Phase II Study of LUNG STereotactic Adaptive Ablative Radiotherapy for Central and Ultracentral Tumors (LUNG STAAR)
Purpose of Study:
The purpose of this research is to offer patients with centrally located early-stage non-small cell lung cancer (NSCLC) who are NOT candidates for surgery the opportunity to receive stereotactic body radiation therapy (SBRT).
May 2, 2022 - October 1, 2032
Miami Cancer Institute at Baptist Health, Inc.
View Ray Inc.
Rupesh Kotecha, M.D.
Contact Phone: 786-596-2000
Contact Email: [email protected]
Miami Cancer Institute at Baptist health, Inc.